Concepedia

Irene McEleavy

IM

Statistics

Publications

5

Citations

1.5K

H-Index

5

Active since

2011

Affiliations

Patan Academy of Health Sciences(Current)

University of Nottingham

Roslin Institute

University of Bristol

Medway NHS Foundation Trust

Irene McEleavy is an author at Patan Academy of Health Sciences specializing in pharmacotherapy, 28-day mortality, and open-label trials.

Publications per year

2011–2023

5

Publications

5

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

, , +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

, , +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

, , +13

A Double-Blind Randomized Controlled Clinical Trial to Assess the Effect of Doppler Optimized Intraoperative Fluid Management on Outcome Following Radical Cystectomy

Praveen Pillai, Irene McEleavy, Matthew Gaughan et al. · The Journal of Urology · 2011 · 138 citations

, , +17

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 132 citations · Full text

, , +17

1–5 of 5